TY - JOUR
T1 - Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset
T2 - A population-based study from Olmsted County, Minnesota
AU - Swami, Sanjeev K.
AU - Liesinger, Juliette T.
AU - Shah, Nilay
AU - Baddour, Larry M.
AU - Banerjee, Ritu
N1 - Funding Information:
Grant Support: This work was supported by funds from the Departments of Medicine and Pediatric and Adolescent Medicine, Mayo Clinic , and National Institute of Health grant RO1 AG034676 , the Rochester Epidemiology Project (Dr Walter A. Rocca, principal investigator).
PY - 2012/8
Y1 - 2012/8
N2 - Objective: To better understand the epidemiology of drug-resistant Escherichia coli across health care and community settings. Patients and Methods: We conducted a population-based cohort study of the incidence of antibiotic-resistant E coli bacteriuria among different patient groups. All urine cultures with monomicrobial growth of E coli obtained from Olmsted County, Minnesota, residents from January 1, 2005, through December 31, 2009, were identified. The initial isolate per patient per year was included. Analyses were stratified by patient age and location of infection onset (ie, nosocomial, health care associated, and community associated). Results: We evaluated 5619 E coli isolates and the associated patients. During the study period, the incidence of drug-resistant bacteriuria did not change among children but increased significantly among adults of all ages, most markedly among elderly patients older than 80 years. In elderly patients, the incidence of bacteriuria with isolates resistant to fluoroquinolones increased from 464 to 1116 per 100,000 person-years (P<.001), and the incidence of bacteriuria with isolates resistant to fluoroquinolones plus trimethoprim-sulfamethoxazole increased from 274 to 512 per 100,000 person-years (P<.05). When analyzed by location of infection onset, incidence of bacteriuria with isolates resistant to trimethoprim-sulfamethoxazole, fluoroquinolones, trimethoprim-sulfamethoxazole plus fluoroquinolones, extended-spectrum cephalosporins, and more than 3 drug classes increased significantly among community-associated but not among nosocomial or health care-associated cases. Conclusion: In this population-based study, the incidence of antibiotic-resistant E coli bacteriuria nearly doubled during the 5-year study period among elderly patients and those with community-associated isolates. These patient groups should be targets of interventions to slow the emergence and spread of antibiotic-resistant E coli.
AB - Objective: To better understand the epidemiology of drug-resistant Escherichia coli across health care and community settings. Patients and Methods: We conducted a population-based cohort study of the incidence of antibiotic-resistant E coli bacteriuria among different patient groups. All urine cultures with monomicrobial growth of E coli obtained from Olmsted County, Minnesota, residents from January 1, 2005, through December 31, 2009, were identified. The initial isolate per patient per year was included. Analyses were stratified by patient age and location of infection onset (ie, nosocomial, health care associated, and community associated). Results: We evaluated 5619 E coli isolates and the associated patients. During the study period, the incidence of drug-resistant bacteriuria did not change among children but increased significantly among adults of all ages, most markedly among elderly patients older than 80 years. In elderly patients, the incidence of bacteriuria with isolates resistant to fluoroquinolones increased from 464 to 1116 per 100,000 person-years (P<.001), and the incidence of bacteriuria with isolates resistant to fluoroquinolones plus trimethoprim-sulfamethoxazole increased from 274 to 512 per 100,000 person-years (P<.05). When analyzed by location of infection onset, incidence of bacteriuria with isolates resistant to trimethoprim-sulfamethoxazole, fluoroquinolones, trimethoprim-sulfamethoxazole plus fluoroquinolones, extended-spectrum cephalosporins, and more than 3 drug classes increased significantly among community-associated but not among nosocomial or health care-associated cases. Conclusion: In this population-based study, the incidence of antibiotic-resistant E coli bacteriuria nearly doubled during the 5-year study period among elderly patients and those with community-associated isolates. These patient groups should be targets of interventions to slow the emergence and spread of antibiotic-resistant E coli.
UR - http://www.scopus.com/inward/record.url?scp=84866410554&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866410554&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2012.02.025
DO - 10.1016/j.mayocp.2012.02.025
M3 - Article
C2 - 22795635
AN - SCOPUS:84866410554
SN - 0025-6196
VL - 87
SP - 753
EP - 759
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 8
ER -